TITLE

The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome

AUTHOR(S)
Pinkas, Haim; Sapir, Onit; Avrech, Ori M.; Ben-Haroush, Avi; Ashkenzi, Jacob; Fisch, Benjamin; Farhi, Jacob
PUB. DATE
January 2008
SOURCE
Journal of Assisted Reproduction & Genetics;Jan2008, Vol. 25 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective To evaluate the effect of oral contraceptive pills (OCP) pretreatment on IVF cycle outcome in GnRH-antagonist protocol. Design Retrospective cohort study. Setting Major tertiary university-affiliated center. Patients All patients treated with GnRH antagonist in our IVF unit during the last 3 years were included in the study. Overall 1,799 IVF cycles were performed. Of these, in 604 cycles OCP pretreatment was used prior to GnRH-antagonist for cycle scheduling. Patients were divided into two age groups--young group aged ≤35 years and older group aged ≥36 years. Interventions The young group underwent 927 cycles, 281 cycles with OCP pretreatment and 646 cycles without. The older group underwent 872 cycles, 323 cycles with OCP pretreatment and 549 cycles without. Data was analyzed within each age group. Main outcome measures Treatment duration and total dose of FSH IU used for stimulation, number of oocytes retrieved, implantation and pregnancy rates. Results All OCP-pretreated cycles required significantly longer stimulation than non-pretreated cycles (young: 10.76 vs. 9.21 days; older: 10.48 vs. 8.73 days, respectively) and higher total dose of FSH IU (young: 3,210 IU vs. 2,565 IU; older: 4,973 IU vs. 3,983 IU, respectively). There were no other differences in cycle characteristics between groups. Implantation and pregnancy rates were not affected by OCP pretreatment. Conclusions OCP pretreatment can be offered as a mode for cycle scheduling prior to GnRH-antagonist protocol, though it may be associated with longer stimulation and higher gonadotropin consumption.
ACCESSION #
32924978

 

Related Articles

  • Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born. Ludwig, M.; Katalinic, A.; Felberbaum, R. E.; Diedrich, K. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p61 

    The safety of ovarian stimulation procedures or the procedure of assisted reproduction in general can be estimated by various parameters. Two of the most important are the health of children born after the procedure and the incidence of ovarian hyperstimulation syndrome (OHSS). The latter is...

  • Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: retrospective insights from ten years experience. Manno, Massimo; Cervi, Marta; Zadro, Donatella; Fuggetta, Giuseppa; Adamo, Valter; Tomei, Francesco // Journal of Assisted Reproduction & Genetics;Aug2011, Vol. 28 Issue 8, p693 

    Purpose: To evaluate the impact of high estradiol (E2) levels on assisted reproductive technologies outcomes in high responders (≥12 oocytes retrieved) according to the controlled ovarian stimulation protocol (COS) used. Methods: Clinical retrospective evaluation of total, clinical...

  • GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial. Prapas, Nikos; Tavaniotou, Asimina; Panagiotidis, Yannis; Prapa, Stella; Kasapi, Evangelia; Goudakou, Maria; Papatheodorou, Achilleas; Prapas, Yannis // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Feb2009, Vol. 18 Issue 2, p276 

    The effect that gonadotrophin-releasing hormone (GnRH) antagonists exert on endometrial receptivity has not yet been elucidated. GnRH antagonists might directly affect oocytes, the embryo and/or the endometrium. The aim of this study was to investigate the direct effect of GnRH antagonists on...

  • Medical and Surgical Treatment of Endometriosis-Associated Infertility and Pain.  // Fertility Weekly;2/24/2003, p6 

    Presents a study on medical and surgical treatment of endometriosis-associated infertility and pain. Benefits of combined gonadotropin-releasing hormone agonist and surgery; Determination of pregnancy rate among patients; Indication of in vitro fertilization as second line of treatment.

  • Does Centre's Experience Influence IVF Success in Patients Undergoing Controlled Ovarian Stimulation with GnRH-Antagonists? Orvieto, Raoul; Zohav, Efraim; Liberty, Gad; Morgante, Giuseppe; Nahum, Ravit; Rabinson, Jacob; Meltcer, Simion // Open Women's Health Journal;2010, Vol. 4, p69 

    In an attempt to examine whether centre's experience may influence IVF outcome in patients undergoing GnRH-antagonists COH protocols, we studied patients, with a favorable prognosis a priori, undergoing 557 consecutive IVF cycles during a 9 years period. Throughout the study period patients...

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. M.J. Pelinck; N.E.A. Vogel; A. Hoek; A.H.M. Simons; E.G.J.M. Arts; M.H. Mochtar; S. Beemsterboer; M.N. Hondelink; M.J. Heineman // Human Reproduction;Sep2006, Vol. 21 Issue 9, p2375 

    BACKGROUND: In minimal stimulation IVF, treatment is aimed at using the single oocyte that spontaneously develops to dominance. To prevent untimely ovulation, a GnRH antagonist is administered in the late follicular phase of the natural cycle together with recombinant FSH for substitution. Owing...

  • Assessing the optimal dose for Cetrorelix in Chinese women undergoing ovarian stimulation during the course of IVF-ET treatment. Qiaohong Lai; Jun Hu; Dan Zeng; Juan Hu; Fuying Cai; Fei Yang; Cai Chen; Xiaoyu He; Ping Yang; Qilin Yu; Shu Zhang; Jun-Fa Xu; Cong-Yi Wang // American Journal of Translational Research;2014, Vol. 6 Issue 1, p78 

    We conducted a prospective, randomized, and controlled trial to assess the optimal dose for GnRH antagonist, cetrorelix, for Chinese women during the course of ovarian stimulation. The patients were randomly divided into two groups, in which 48 patients were advised to inject 0.25 mg Cetrorelix...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics